Our Opinion

Bionomics Limited is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“The first compound has completed Phase 1 safety clinical trials in healthy subjects and is undergoing biomarker studies. In 2020, a second molecule that showed an improved potency profile in preclinical animal models was advanced by Merck under this collaboration into Phase 1 clinical trials.” Read the following article

Company Description

Bionomics Ltd operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a pipeline of novel therapeutic ion channel targeting drug candidates to improve the lives of patients suffering from central nervous system (CNS) disorders. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Company Website: https://www.bionomics.com.au